Generic biotech drugs may be getting a serious boost: part of President Obama's budget is designed to foster development of these follow-on biologics. Over at Patent Baristas, Stephen Albainy-Jenei blogs about the Biotechnology Industry Organization's response at a press conference.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.